This routine 10b5-1 plan sale by a director is unlikely to move the stock. Monitor for any unplanned insider sales, but this filing alone does not warrant action.
CGON drugs
CGON drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 23 $65.73entry
- T+1 · 5mo ago +4.55%α +4.60% · $68.72
- T+5 · 5mo ago +12.17%α +11.16% · $73.73
- T+20 · 4mo ago +6.79%α +5.63% · $70.19
- T+60 · 2mo ago +12.76%α +9.52% · $74.12
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CG Oncology director Leonard Post filed a Form 144 indicating intent to sell 6,000 shares (~$366K) under a 10b5-1 plan, likely to exercise stock options. The sale is small relative to market cap ($5.4B) and pre-planned, carrying minimal signal.
Key Facts
- Insider: Leonard E. Post, Director
- Shares to sell: 6,000 common shares
- Estimated value: $366,480 (based on $61.08/share)
- Sale method: Morgan Stanley Smith Barney, pre-arranged 10b5-1 plan
- Acquisition: Upon exercise of stock options over next three months
- Prior sale: 1,000 shares on 06/04/2026 for $54,500
Financial Impact
~$366K, less than 0.01% of market cap
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-006393 |
| Document: 0001950047-26-006393-index.html | 0001950047-26-006393 |
| Document: 0001950047-26-006393.txt | 0001950047-26-006393 |
Track record
25 reports on CGON
6 of 7 bullish or bearish reports moved the stock their way by T+20. Best: +26.33% at T+20 after the Jun 12, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today 8-K Bullish 7/10 Entry $98.84 Now $84.78 −14.23% settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $95.01 Now $84.78 −10.77% settles Dec 15
- Nov 6, 202610d ago 8-K Bearish 5/10 Entry $75.99 Now $84.78 −11.57% settles Dec 7
- Nov 6, 202610d ago Press Release Neutral 4/10 Entry $75.99 Now $84.78 +11.57% settles Dec 7
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $64.06 Now $84.78 +32.34% settles Dec 2
- Oct 19, 202628d ago 3 Neutral 2/10 Entry $61.93 Now $84.78 +36.90% settles Nov 17
- Oct 15, 20264w ago 144 Neutral 2/10 Entry $59.85 to $74.40 Now $84.78 +41.65% ▲ +24.31% +25.47% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $63.13 to $74.74 Now $84.78 +34.29% ▲ +18.39% +21.66% vs SPY
- Aug 6, 202614w ago Press Release Bearish 7/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
- Aug 6, 202614w ago 424B5 Bearish 6/10 Entry $74.85 to $74.33 Now $84.78 −13.27% ▲ +0.69% +1.29% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers